{"componentChunkName":"component---src-templates-chapter-level-2-chapter-level-2-tsx","path":"/topics/diverticular-disease/prescribing-information/cefalexin/","result":{"pageContext":{"chapter":{"id":"ba178fdc-1c2f-58e1-aec7-b1f903ed5207","slug":"cefalexin","fullItemName":"Cefalexin","depth":2,"htmlHeader":"<!-- begin field 79c163bf-1744-497c-9cbc-ab1b00e4b297 --><h2>Cefalexin</h2><!-- end field 79c163bf-1744-497c-9cbc-ab1b00e4b297 -->","summary":"","htmlStringContent":"<!-- begin item c0493f9a-c7ae-481f-bd16-ab1b00e4b26e --><!-- end item c0493f9a-c7ae-481f-bd16-ab1b00e4b26e -->","topic":{"id":"94c44346-c791-5b97-9e45-bacb8fe90589","topicId":"eee234d5-c667-4944-95d2-a45f5e032286","topicName":"Diverticular disease","slug":"diverticular-disease","lastRevised":"Last revised in January 2021","chapters":[{"id":"5bcd7ed5-7ab4-57a1-a517-99ee8bb7b2d5","fullItemName":"Summary","slug":"summary","subChapters":[]},{"id":"5abc06b8-fef4-5d67-81ce-ee1c71284864","fullItemName":"Have I got the right topic?","slug":"have-i-got-the-right-topic","subChapters":[]},{"id":"71ba91f6-898b-5f69-bd52-93f3b1892ad6","fullItemName":"How up-to-date is this topic?","slug":"how-up-to-date-is-this-topic","subChapters":[{"id":"7460514b-3977-52be-9e12-06486604b194","slug":"changes","fullItemName":"Changes"},{"id":"909831b0-6f3c-5e85-8263-a5e1785b8a49","slug":"update","fullItemName":"Update"}]},{"id":"fcd203c7-5d1a-5fcc-ab90-5286ab76bd2d","fullItemName":"Goals and outcome measures","slug":"goals-outcome-measures","subChapters":[{"id":"2cbe6fe5-f942-566e-9136-915145ba8517","slug":"goals","fullItemName":"Goals"},{"id":"ffcabc25-6966-526d-8382-a5fcf56185ab","slug":"outcome-measures","fullItemName":"Outcome measures"},{"id":"dc0b24e2-e0db-5829-baf5-a7aae6d5ab67","slug":"audit-criteria","fullItemName":"Audit criteria"},{"id":"b5dcfe41-ec7c-5a9f-bc96-229f8b818a77","slug":"qof-indicators","fullItemName":"QOF indicators"},{"id":"d9311147-ff58-5778-bb86-c0249937ef45","slug":"qipp-options-for-local-implementation","fullItemName":"QIPP - Options for local implementation"},{"id":"5b76632c-4924-5c26-99ab-549b62bb2f73","slug":"nice-quality-standards","fullItemName":"NICE quality standards"}]},{"id":"435ea69d-fb08-554b-b803-cc64d393575b","fullItemName":"Background information","slug":"background-information","subChapters":[{"id":"12666ff2-dbf6-51be-b83a-78c0d4aa12e3","slug":"definition","fullItemName":"Definition"},{"id":"3a4412ce-ae17-58e7-8460-9ab759755b96","slug":"risk-factors","fullItemName":"Risk factors"},{"id":"11908cbc-fb2b-525e-9bed-e9da60b6ad8a","slug":"prevalence","fullItemName":"Prevalence"},{"id":"2efdd449-ac81-531a-9514-72e57632cf72","slug":"complications","fullItemName":"Complications"},{"id":"2bb98737-1604-5f47-8f96-27003159f003","slug":"prognosis","fullItemName":"Prognosis"}]},{"id":"b9740a9c-8383-57e1-8cc6-7fea164147c7","fullItemName":"Diagnosis","slug":"diagnosis","subChapters":[{"id":"411e61cd-aad7-5e40-bf27-38061aae07cb","slug":"diagnosis","fullItemName":"Diagnosis"},{"id":"21f90600-3a9d-5e53-92e4-7305f17db5aa","slug":"differential-diagnosis","fullItemName":"Differential diagnosis"}]},{"id":"c90663d3-95e7-5f18-9718-27a43a51abbf","fullItemName":"Management","slug":"management","subChapters":[{"id":"43142f56-faaf-50dc-a1b7-1d4fb26d1a5e","slug":"diverticulosis","fullItemName":"Scenario: Diverticulosis"},{"id":"a1baccf2-7945-577b-b755-eff86d33201c","slug":"diverticular-disease","fullItemName":"Scenario: Diverticular disease"},{"id":"0c23dfbe-5e71-5eeb-9b03-6b3377f49225","slug":"acute-diverticulitis","fullItemName":"Scenario: Acute diverticulitis"}]},{"id":"b30de8ba-1b8a-5f97-83ef-4d6ebc76ae50","fullItemName":"Prescribing information","slug":"prescribing-information","subChapters":[{"id":"2bc84877-2507-5c10-af40-fef065820ce1","slug":"bulk-forming-laxatives","fullItemName":"Bulk-forming laxatives"},{"id":"ba178fdc-1c2f-58e1-aec7-b1f903ed5207","slug":"cefalexin","fullItemName":"Cefalexin"},{"id":"524ca556-9a60-542a-9102-901470ef4882","slug":"co-amoxiclav","fullItemName":"Co-amoxiclav"},{"id":"463ca371-3542-5765-8350-4a0a640f0cae","slug":"ciprofloxacin","fullItemName":"Ciprofloxacin"},{"id":"231102c0-511c-5785-ac06-8720d28571cb","slug":"metronidazole","fullItemName":"Metronidazole"},{"id":"f2cde7d6-3b3a-5b9f-bf9c-9c7445a1ae6f","slug":"trimethoprim","fullItemName":"Trimethoprim"}]},{"id":"8b942243-eed9-557a-9678-01f6c77e2b91","fullItemName":"Supporting evidence","slug":"supporting-evidence","subChapters":[]},{"id":"7ccd6405-b8ec-557d-9d70-bce3f43accbd","fullItemName":"How this topic was developed","slug":"how-this-topic-was-developed","subChapters":[{"id":"544db73d-5bf7-5ac9-81f4-784210ec7343","slug":"search-strategy","fullItemName":"Search strategy"},{"id":"f2fb4d8d-7ad7-55ef-837b-a9faa80ba34d","slug":"stakeholder-engagement","fullItemName":"Stakeholder engagement"},{"id":"8cbe5c96-baf1-5b25-af5c-6f36a3d9ea3c","slug":"evidence-exclusion-criteria","fullItemName":"Evidence exclusion criteria"},{"id":"7518d3a3-e804-5074-908b-2b9f984cbf60","slug":"organizational-behavioural-financial-barriers","fullItemName":"Organizational, behavioural and financial barriers"},{"id":"e84d6049-8652-59d8-a02d-c49972295f21","slug":"declarations-of-interest","fullItemName":"Declarations of interest"}]},{"id":"1de75d4a-a4c8-5742-add9-eabcb6711bcb","fullItemName":"References","slug":"references","subChapters":[]}]},"parentChapter":{"id":"b30de8ba-1b8a-5f97-83ef-4d6ebc76ae50","slug":"prescribing-information","fullItemName":"Prescribing information"},"subChapters":[{"id":"8c8cdb4a-fb12-593e-b9c6-f881c79fc3ea","slug":"cautions-contraindications","fullItemName":"Cautions and contraindications","depth":3,"htmlHeader":"<!-- begin field 82021c1e-b27d-4513-a874-ab1b00e539d4 --><h3>Cautions and contraindications</h3><!-- end field 82021c1e-b27d-4513-a874-ab1b00e539d4 -->","summary":"","htmlStringContent":"<!-- begin item 2118f540-5cc5-49de-a009-ab1b00e539b7 --><!-- begin field 658f764e-c030-4df8-90b9-ab1b00e539d4 --><ul><li><strong>Do not prescribe cefalexin in people with: </strong><ul><li>A known allergy to the cephalosporin group of antibiotics or a history of immediate hypersensitivity to penicillin and other beta-lactams.</li></ul></li><li><strong>Prescribe cefalexin with caution in people with:</strong><ul><li>Sensitivity to penicillin and other beta lactams. About 0.5–6.5% of penicillin-sensitive people will also be allergic to cephalosporins.</li></ul></li></ul><p>[<a class=\"bibliography-reference internal-reference\" href=\"/topics/diverticular-disease/references/\">ABPI, 2017a</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/diverticular-disease/references/\">BNF 74, 2017</a>] </p><!-- end field 658f764e-c030-4df8-90b9-ab1b00e539d4 --><!-- end item 2118f540-5cc5-49de-a009-ab1b00e539b7 -->","subChapters":[]},{"id":"82ffd996-7b94-5935-8140-a9d21972ad05","slug":"adverse-effects","fullItemName":"Adverse effects","depth":3,"htmlHeader":"<!-- begin field 7c8195ba-9d3d-447b-a818-ab1b00e5469b --><h3>Adverse effects</h3><!-- end field 7c8195ba-9d3d-447b-a818-ab1b00e5469b -->","summary":"","htmlStringContent":"<!-- begin item 7ccb582d-1a68-4b83-92ee-ab1b00e54683 --><!-- begin field d27e8c48-239c-457d-92b0-ab1b00e5469b --><ul><li><strong>Gastrointestinal </strong>— diarrhoea (most common), nausea, vomiting, abdominal discomfort.</li><li><strong>Nervous system</strong> — headache, dizziness.</li><li><strong>Psychiatric </strong>— hallucinations, confusion, agitation.</li><li><strong>Skin</strong> – rash urticaria, angioedema.<ul><li><strong>Rarely:</strong> erythema multiforme, Stevens-Johnson syndrome and toxic epidermal necrolysis (exanthematic necrolysis)</li></ul></li><li><strong>Other adverse effects include:</strong> <ul><li>Anaphylaxis.</li><li>Arthralgia and myalgia.</li><li>Eosinophilia, neutropenia, thrombocytopenia, haemolytic anaemia. </li><li>Genital and anal pruritus.</li><li>Hepatitis, cholestatic jaundice.</li><li>Interstitial nephritis (rarely).</li><li>Pseudomembranous colitis (for more information, see the CKS topic on <a class=\"topic-reference external-reference\" href=\"/topics/diarrhoea-antibiotic-associated/\">Diarrhoea - antibiotic associated</a>.</li></ul></li></ul><p>[<a class=\"bibliography-reference internal-reference\" href=\"/topics/diverticular-disease/references/\">ABPI, 2017a</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/diverticular-disease/references/\">BNF 74, 2017</a>] </p><!-- end field d27e8c48-239c-457d-92b0-ab1b00e5469b --><!-- end item 7ccb582d-1a68-4b83-92ee-ab1b00e54683 -->","subChapters":[]},{"id":"d1207dee-d46b-5a19-8f31-9a4deee8300e","slug":"drug-interactions","fullItemName":"Drug interactions","depth":3,"htmlHeader":"<!-- begin field 2bb98477-8321-47d8-b81e-ab1b00e55349 --><h3>Drug interactions</h3><!-- end field 2bb98477-8321-47d8-b81e-ab1b00e55349 -->","summary":"","htmlStringContent":"<!-- begin item 7e87ad57-0c10-4a4a-8c93-ab1b00e55331 --><!-- begin field 11e33b2e-5234-493a-a640-ab1b00e55349 --><ul><li><strong>Aminoglycosides </strong>(for example, gentamicin) — possible increased risk of nephrotoxicity. Routine renal monitoring for the aminoglycoside is usually adequate.</li><li><strong>Oral anticoagulants </strong>(warfarin and phenindione) — cefalexin may enhance the anticoagulant effect. Monitor the international normalized ratio (INR) closely during concomitant use. </li><li><strong>Oral hormonal contraception</strong> — additional contraceptive precautions are not required during or after courses of cefalexin.<ul><li>However, women should be advised about the importance of correct contraceptive practice if they experience vomiting or diarrhoea. For further information, see the sections on vomiting or diarrhoea in the CKS topics on <a class=\"topic-reference external-reference\" href=\"/topics/contraception-combined-hormonal-methods/\">Contraception - combined hormonal methods</a> and <a class=\"topic-reference external-reference\" href=\"/topics/contraception-progestogen-only-methods/\">Contraception - progestogen-only methods</a>.</li></ul></li><li><strong>Probenecid</strong> — renal excretion of cefalexin is inhibited. However, no dose adjustment is normally required.</li></ul><p>[<a class=\"bibliography-reference internal-reference\" href=\"/topics/diverticular-disease/references/\">Preston, 2016</a>]  [<a class=\"bibliography-reference internal-reference\" href=\"/topics/diverticular-disease/references/\">ABPI, 2017a</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/diverticular-disease/references/\">BNF 74, 2017</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/diverticular-disease/references/\">FSRH, 2017</a>] </p><!-- end field 11e33b2e-5234-493a-a640-ab1b00e55349 --><!-- end item 7e87ad57-0c10-4a4a-8c93-ab1b00e55331 -->","subChapters":[]},{"id":"1023dec9-7fd6-57ca-9f7c-43896493ff65","slug":"pregnancy-breastfeeding","fullItemName":"Pregnancy and breastfeeding","depth":3,"htmlHeader":"<!-- begin field 0b9df999-7ecf-497a-bb04-ab1b00e56140 --><h3>Pregnancy and breastfeeding</h3><!-- end field 0b9df999-7ecf-497a-bb04-ab1b00e56140 -->","summary":"","htmlStringContent":"<!-- begin item 0456419f-8db5-4df3-acfc-ab1b00e5612b --><!-- begin field 5704c146-f337-473a-9f25-ab1b00e56140 --><h4>Pregnancy</h4><ul><li>Cefalexin is not known to be harmful in pregnancy.</li></ul><h4>Breastfeeding</h4><ul><li>Trace amounts of cefalexin are found in breastmilk – it is not known to be harmful to breastfed children.<ul><li>Cephalosporins (and penicillins) are the antibiotics of choice in women who are breastfeeding.</li></ul></li></ul><p>[<a class=\"bibliography-reference internal-reference\" href=\"/topics/diverticular-disease/references/\">Kearney, 2016</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/diverticular-disease/references/\">ABPI, 2017a</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/diverticular-disease/references/\">BNF 74, 2017</a>]</p><!-- end field 5704c146-f337-473a-9f25-ab1b00e56140 --><!-- end item 0456419f-8db5-4df3-acfc-ab1b00e5612b -->","subChapters":[]}]}}},"staticQueryHashes":["3666801979"]}